Utah Medical Products (UTMD) Competitors $58.30 +0.82 (+1.42%) As of 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTMD vs. CERS, OSUR, ANIK, WST, COO, ALGN, MMSI, HAE, ICUI, and XRAYShould you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Utah Medical Products vs. Its Competitors Cerus OraSure Technologies Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical DENTSPLY SIRONA Utah Medical Products (NASDAQ:UTMD) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership. Which has higher valuation & earnings, UTMD or CERS? Utah Medical Products has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUtah Medical Products$40.90M4.63$13.87M$3.7815.42Cerus$180.27M1.59-$20.92M-$0.10-15.00 Does the media prefer UTMD or CERS? In the previous week, Utah Medical Products and Utah Medical Products both had 1 articles in the media. Cerus' average media sentiment score of 1.49 beat Utah Medical Products' score of 0.38 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Utah Medical Products 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cerus 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, UTMD or CERS? Utah Medical Products has a beta of 0.28, meaning that its stock price is 72% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Do analysts recommend UTMD or CERS? Cerus has a consensus price target of $3.50, indicating a potential upside of 133.33%. Given Cerus' stronger consensus rating and higher probable upside, analysts plainly believe Cerus is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in UTMD or CERS? 69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 7.4% of Utah Medical Products shares are owned by insiders. Comparatively, 5.6% of Cerus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is UTMD or CERS more profitable? Utah Medical Products has a net margin of 33.00% compared to Cerus' net margin of -10.23%. Utah Medical Products' return on equity of 10.74% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Utah Medical Products33.00% 10.74% 10.27% Cerus -10.23%-34.81%-9.68% SummaryUtah Medical Products beats Cerus on 8 of the 15 factors compared between the two stocks. Get Utah Medical Products News Delivered to You Automatically Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTMD vs. The Competition Export to ExcelMetricUtah Medical ProductsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$186.72M$10.51B$5.54B$8.95BDividend Yield2.12%2.09%5.38%4.08%P/E Ratio15.4216.7427.4020.04Price / Sales4.6329.51419.46118.60Price / Cash11.6622.8436.6357.47Price / Book1.683.668.085.67Net Income$13.87M$235.40M$3.16B$248.47M7 Day Performance3.30%1.89%2.12%2.90%1 Month Performance4.12%3.83%4.43%5.75%1 Year Performance-12.16%-10.20%35.62%21.36% Utah Medical Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTMDUtah Medical Products2.3424 of 5 stars$58.31+1.4%N/A-13.0%$186.72M$40.90M15.42180News CoverageCERSCerus3.1333 of 5 stars$1.34flat$3.50+161.2%-8.2%$256.15M$180.27M-13.40290Positive NewsOSUROraSure Technologies1.0309 of 5 stars$3.03+1.0%$3.00-1.0%-25.0%$224.40M$185.83M-7.21840ANIKAnika Therapeutics3.7416 of 5 stars$10.92+3.1%$20.00+83.2%-56.8%$151.88M$119.91M-2.81300News CoverageWSTWest Pharmaceutical Services4.7645 of 5 stars$217.05+0.6%$332.50+53.2%-31.4%$15.51B$2.89B34.0710,600Trending NewsCOOCooper Companies3.4283 of 5 stars$69.52+0.1%$99.70+43.4%-15.6%$13.89B$3.90B33.7516,000Trending NewsHigh Trading VolumeALGNAlign Technology4.6202 of 5 stars$183.42+0.9%$241.25+31.5%-17.8%$13.18B$4.00B33.4120,945Positive NewsMMSIMerit Medical Systems4.3697 of 5 stars$92.32+0.4%$109.11+18.2%+8.1%$5.44B$1.36B45.267,400News CoveragePositive NewsHAEHaemonetics4.8148 of 5 stars$72.15+1.5%$97.89+35.7%-8.2%$3.41B$1.36B21.803,023ICUIICU Medical4.5265 of 5 stars$128.07+0.3%$192.67+50.4%+15.9%$3.14B$2.38B-33.4415,000News CoverageXRAYDENTSPLY SIRONA4.4978 of 5 stars$15.48+0.8%$20.36+31.5%-32.2%$3.06B$3.79B-3.4114,000Positive News Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives Haemonetics Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTMD) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
